Analysts Anticipate Motif Bio plc – (MTFB) to Announce -$0.96 EPS

Equities analysts expect Motif Bio plc – (NASDAQ:MTFB) to report ($0.96) earnings per share (EPS) for the current fiscal quarter, according to Zacks. Zero analysts have provided estimates for Motif Bio’s earnings, with the lowest EPS estimate coming in at ($1.15) and the highest estimate coming in at ($0.76). The business is expected to issue its next earnings report on Monday, May 7th.

On average, analysts expect that Motif Bio will report full year earnings of ($2.86) per share for the current fiscal year, with EPS estimates ranging from ($3.38) to ($2.14). For the next year, analysts expect that the firm will post earnings of ($1.68) per share, with EPS estimates ranging from ($2.30) to ($1.06). Zacks’ earnings per share averages are a mean average based on a survey of sell-side analysts that follow Motif Bio.

MTFB has been the topic of a number of research analyst reports. HC Wainwright set a $32.00 price objective on shares of Motif Bio and gave the company a “buy” rating in a research note on Wednesday, October 11th. WBB Securities assumed coverage on shares of Motif Bio in a research note on Friday, December 29th. They set a “sell” rating and a $7.00 price objective on the stock. Finally, Seaport Global Securities restated a “buy” rating on shares of Motif Bio in a research report on Friday, December 22nd.

Motif Bio (MTFB) opened at $11.15 on Thursday. Motif Bio has a 52 week low of $5.36 and a 52 week high of $13.75.

ILLEGAL ACTIVITY WARNING: This news story was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this news story on another domain, it was stolen and republished in violation of United States and international copyright & trademark laws. The correct version of this news story can be viewed at https://www.com-unik.info/2018/01/11/analysts-anticipate-motif-bio-plc-mtfb-to-announce-0-96-eps.html.

Get a free copy of the Zacks research report on Motif Bio (MTFB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Motif Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motif Bio and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit